Rx/Reimbursement Adult Incontinence in Argentina

Rx/Reimbursement Adult Incontinence in Argentina


The National Institute of Social Services for Retirees and Pensioners (PAMI) is the public institution charged with providing healthcare coverage to elderly people in Argentina, a remit that includes the distribution of Rx/reimbursement adult incontinence products. Operating via a nationwide network of 650 subsidiaries, it has approximately 4.8 million members, around 700,000 of whom live in the city of Buenos Aires. By the end of the review period, it was distributing roughly 15 million adult i...

Euromonitor International's Rx/Reimbursement adult incontinence in Argentina report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2019-2023, allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market – be they new product developments, distribution or pricing issues. Forecasts to 2028 illustrate how the market is set to change.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
* Get a detailed picture of the Rx/Reimbursement adult incontinence market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.


Rx/Reimbursement Adult Incontinence in Argentina
Euromonitor International
February 2024
List Of Contents And Tables
RX/REIMBURSEMENT ADULT INCONTINENCE IN ARGENTINA
KEY DATA FINDINGS
2023 DEVELOPMENTS
PAMI retains overall responsibility for distribution of Rx/reimbursement products
Return to the previous distribution scheme
Only two companies serve as PAMI providers
PROSPECTS AND OPPORTUNITIES
Price adjustment by PAMI anticipated
Increasing pressure on public finances due to ageing population
Skin care considerations and PAMI's priorities
CATEGORY DATA
Table 1 Sales of Rx/Reimbursement Adult Incontinence: Total Value MSP 2018-2023
Table 2 Sales of Rx/Reimbursement Adult Incontinence: Total Value MSP Growth 2018-2023
Table 3 Forecast Sales of Rx/Reimbursement Adult Incontinence: Total Value MSP 2023-2028
Table 4 Forecast Sales of Rx/Reimbursement Adult Incontinence: Total Value MSP Growth 2023-2028
TISSUE AND HYGIENE IN ARGENTINA
EXECUTIVE SUMMARY
Tissue and hygiene in 2023: The big picture
2023 key trends
Competitive landscape
Retailing developments
What next for tissue and hygiene?
MARKET INDICATORS
Table 5 Birth Rates 2018-2023
Table 6 Infant Population 2018-2023
Table 7 Female Population by Age 2018-2023
Table 8 Total Population by Age 2018-2023
Table 9 Households 2018-2023
Table 10 Forecast Infant Population 2023-2028
Table 11 Forecast Female Population by Age 2023-2028
Table 12 Forecast Total Population by Age 2023-2028
Table 13 Forecast Households 2023-2028
MARKET DATA
Table 14 Retail Sales of Tissue and Hygiene by Category: Value 2018-2023
Table 15 Retail Sales of Tissue and Hygiene by Category: % Value Growth 2018-2023
Table 16 NBO Company Shares of Retail Tissue and Hygiene: % Value 2019-2023
Table 17 LBN Brand Shares of Retail Tissue and Hygiene: % Value 2020-2023
Table 18 Penetration of Private Label in Retail Tissue and Hygiene by Category: % Value 2018-2023
Table 19 Distribution of Retail Tissue and Hygiene by Format: % Value 2018-2023
Table 20 Distribution of Retail Tissue and Hygiene by Format and Category: % Value 2023
Table 21 Forecast Retail Sales of Tissue and Hygiene by Category: Value 2023-2028
Table 22 Forecast Retail Sales of Tissue and Hygiene by Category: % Value Growth 2023-2028
DISCLAIMER
SOURCES
Summary 1 Research Sources

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings